ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 132 filers reported holding ANAPTYSBIO INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,091,950 | -55.4% | 60,799 | -49.5% | 0.00% | – |
| Q2 2023 | $2,447,208 | -2.0% | 120,315 | +4.8% | 0.00% | – |
| Q1 2023 | $2,497,199 | +2.8% | 114,761 | +46.4% | 0.00% | – |
| Q4 2022 | $2,428,934 | +17.5% | 78,378 | -3.3% | 0.00% | – |
| Q3 2022 | $2,067,000 | +119.2% | 81,049 | +74.4% | 0.00% | – |
| Q2 2022 | $943,000 | +11.5% | 46,482 | +35.9% | 0.00% | – |
| Q1 2022 | $846,000 | +151.8% | 34,212 | +254.2% | 0.00% | – |
| Q4 2021 | $336,000 | -13.0% | 9,658 | -32.2% | 0.00% | – |
| Q3 2021 | $386,000 | -4.2% | 14,238 | -8.4% | 0.00% | – |
| Q2 2021 | $403,000 | -63.8% | 15,549 | -69.9% | 0.00% | – |
| Q1 2021 | $1,113,000 | +390.3% | 51,628 | +387.5% | 0.00% | – |
| Q4 2020 | $227,000 | -7.3% | 10,590 | -36.3% | 0.00% | – |
| Q3 2020 | $245,000 | -52.9% | 16,618 | -28.6% | 0.00% | – |
| Q2 2020 | $520,000 | -71.2% | 23,281 | -81.8% | 0.00% | – |
| Q1 2020 | $1,804,000 | +26.7% | 127,646 | +45.7% | 0.00% | – |
| Q4 2019 | $1,424,000 | +167.7% | 87,604 | +475.1% | 0.00% | – |
| Q3 2019 | $532,000 | -82.4% | 15,234 | -71.6% | 0.00% | – |
| Q2 2019 | $3,024,000 | +16.2% | 53,593 | +50.4% | 0.00% | – |
| Q1 2019 | $2,603,000 | +826.3% | 35,635 | +710.4% | 0.00% | – |
| Q4 2018 | $281,000 | -92.8% | 4,397 | -88.8% | 0.00% | – |
| Q3 2018 | $3,923,000 | -40.0% | 39,330 | -57.3% | 0.00% | -100.0% |
| Q2 2018 | $6,540,000 | +92.4% | 92,051 | +181.8% | 0.00% | – |
| Q1 2018 | $3,400,000 | +465.7% | 32,664 | +447.8% | 0.00% | – |
| Q4 2017 | $601,000 | +2905.0% | 5,963 | +933.4% | 0.00% | – |
| Q3 2017 | $20,000 | -83.5% | 577 | -88.5% | 0.00% | – |
| Q2 2017 | $121,000 | -1.6% | 5,039 | +13.7% | 0.00% | – |
| Q1 2017 | $123,000 | – | 4,433 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,628,678 | $65,033,000 | 13.01% |
| EcoR1 Capital, LLC | 7,521,024 | $186,070,000 | 5.82% |
| GREAT POINT PARTNERS LLC | 700,000 | $17,318,000 | 4.18% |
| Frazier Life Sciences Management, L.P. | 899,700 | $22,259,000 | 1.90% |
| Boxer Capital, LLC | 1,300,000 | $32,162,000 | 1.65% |
| Logos Global Management LP | 300,000 | $7,422,000 | 0.96% |
| Deep Track Capital, LP | 558,782 | $13,824,000 | 0.89% |
| Palo Alto Investors LP | 431,024 | $10,664,000 | 0.82% |
| TCG Crossover Management, LLC | 58,515 | $1,448,000 | 0.58% |
| Rock Springs Capital Management LP | 563,300 | $13,936,000 | 0.35% |